title: Empowered Antibody Therapies - IBC conference.
abstract: The Empowered Antibody Therapies conference, held in Burlingame, CA, USA, included topics covering new therapeutic developments in the field of multispecific antibodies. This conference report highlights selected presentations on DVD-Igs from Abbott Laboratories, ImmTACs from Immunocore, 'Dock-and-Lock' technology from Immunomedics, the bispecific BiTE antibody blinatumomab from Micromet, and Triomabs from TRION Pharma and Fresenius Biotech.
authors.affiliation: TRION Pharma, Frankfurter Ring 193a, 80807 Munich, Germany. jens.herold@trionpharma.de
authors.forename: Jens
authors.initials: J
authors.lastname: Herold
mesh_terms: D000818:Animals; D000906:Antibodies / Q000235:genetics*; D018033:Antibodies, Bispecific / Q000494:pharmacology / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D015507:Drugs, Investigational / Q000494:pharmacology; D006801:Humans; D007116:Immunization, Passive; D051379:Mice; D058990:Molecular Targeted Therapy; D051381:Rats
chemical_list: D000906:Antibodies; D018033:Antibodies, Bispecific; D015507:Drugs, Investigational; C510808:blinatumomab